PillFamotidine
Famotidine
5 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it5 active · 1 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Sagent Pharmaceuticals | unknown | 6 | SUPPLYING |
| Fresenius Kabi USA, LLC | unknown | 4 | SUPPLYING |
| HF Acquisition Co LLC, DBA HealthFirst | unknown | 2 | SUPPLYING |
| Baxter Healthcare Corporation | unknown | 1 | SUPPLYING |
| Medical Purchasing Solutions, LLC | unknown | 1 | SUPPLYING |
| Athenex Pharmaceutical Division, LLC. | unknown | 1 | EXITED 2026 |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Nov 6, 2025RECALLRecall (Class I): Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL vials, Rx only, Fresenius Kabi USA, LLC, NDC 63323-739-1…
Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing. — Recalling firm: Fresenius Kabi USA, LLC — Nationwide within the United States as well as AK, HI, and PR.
- Jun 17, 2020RECALLRecall (Class III): Famotidine Injection, USP, 20 mg/2mL, 2 mL vial, Rx only, Single Dose Vial, For Intravenous Use Only After Dilution, Di…
TEMPERATURE ABUSE: Complaint received from customer that product was received in a non-refrigerated state. — Recalling firm: HF Acquisition Co. LLC — The vials were distributed to one consignee located in CT.
- Apr 24, 2014RECALLRecall (Class II): Famotidine Injection 20 mg, Rx Only, GALAXY Single Dose Container, Code 2G3424, Sterile Nonpyrogenic, 50 mL Iso-osmotic…
Presence of Particulate Matter: Baxter Healthcare Corporation has received a complaint reporting the presence of particulate matter identified as plastic/rubber in famotidine Injection premixed containers. — Recalling firm: Baxter Healthcare Corp. — Nationwide